Butterfly Network (BFLY) Non-Current Assets (2020 - 2026)
Butterfly Network (BFLY) posted Non-Current Assets of $45.0 million for Q2 2026, down 2.35% sequentially from $46.1 million in Q1 2026, and down 24.33% YoY from $59.5 million in Q2 2025.
Butterfly Network (BFLY) Non-Current Assets (2020 - 2026) Analysis & Trends
Butterfly Network has reported Non-Current Assets for 7 years, with the latest figure at $45.0 million in Q2 2026.
- Quarterly Non-Current Assets fell 24.33% year-over-year to $45.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $187.2 million (down 25.05% YoY) and the FY2025 annual result came in at $47.4 million, down 25.27% from the prior year.
- Non-Current Assets fell to $45.0 million in Q2 2026 per BFLY's latest filing, from $46.1 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $73.0 million in Q4 2023 and troughed at $45.0 million in Q2 2026.
- A 5-year average of $61.7 million and a median of $62.3 million in 2022 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets jumped 92.34% in 2022, then fell 26.1% in 2025.
- Over 5 years, Non-Current Assets stood at $60.4 million in 2022, then grew by 20.81% to $73.0 million in 2023, then fell by 13.07% to $63.5 million in 2024, then decreased by 25.27% to $47.4 million in 2025, then decreased by 5.02% to $45.0 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $45.0 million, $46.1 million, and $47.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Butterfly Network | 2.40 Bn | 2.28 Bn | 23.29 Mn | 45.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.05 Mn |
| Mar 31, 2026 | 46.13 Mn |
| Dec 31, 2025 | 47.43 Mn |
| Sep 30, 2025 | 48.61 Mn |
| Jun 30, 2025 | 59.53 Mn |
| Mar 31, 2025 | 61.03 Mn |
| Dec 31, 2024 | 63.47 Mn |
| Sep 30, 2024 | 65.78 Mn |
| Jun 30, 2024 | 68.59 Mn |
| Mar 31, 2024 | 71.02 Mn |
| Dec 31, 2023 | 73.01 Mn |
| Sep 30, 2023 | 65.64 Mn |
| Jun 30, 2023 | 72.76 Mn |
| Mar 31, 2023 | 59.16 Mn |
| Dec 31, 2022 | 60.43 Mn |
| Sep 30, 2022 | 70.79 Mn |
| Jun 30, 2022 | 71.13 Mn |
| Mar 31, 2022 | 61.11 Mn |
| Dec 31, 2021 | 60.06 Mn |
| Sep 30, 2021 | 36.81 Mn |